Gene transfer in regenerating muscle.
We have compared the efficiency of direct gene transfer in normal and regenerating rat skeletal muscle. Muscle necrosis and regeneration was induced by intramuscular injection of bupivacaine in the soleus muscle of adult rats. Plasmids containing beta-galactosidase (beta-gal) or chloramphenicol acetyltransferase (CAT) genes driven by viral promoters were injected 3 days after bupivacaine treatment into the regenerating and the contralateral uninjured muscles. Expression of CAT activity was > 80-fold higher in regenerating compared to control muscles at 7 days post-transfection, but decreased at 30 and 60 days. Southern blot analysis showed that the predominant form of CAT DNA was episomal in transfected muscles; however, CAT activity measurements performed on the same transfected muscles showed no precise correlation between enzymatic activity and amount of plasmid DNA. Expression of beta-gal was detected in numerous regenerating fibers of the injured soleus muscles at 7 days post-transfection; in contrast, only rare positive fibers were found in control muscles. Focal infiltrates of mononuclear cells, which surround and invade selectively beta-gal-positive fiber segments, were observed at 30 days post-transfection, suggesting that immune mechanisms are implicated in the progressive loss of transgenes with time. The finding that regenerating muscle fibers display a higher efficiency of transfection may be relevant to gene therapy of Duchenne muscular dystrophy, because regenerating fibers are numerous in the early stages of the disease.
Vitadello
M
M
CNR Unit for Muscle Biology and Physiopathology, Biotechnology (CRIBI), University of Padova, Italy.
Schiaffino
M V
MV
Picard
A
A
Scarpa
M
M
Schiaffino
S
S
D000818:Animals; D015139:Blotting, Southern; D002045:Bupivacaine; D015500:Chloramphenicol O-Acetyltransferase / Q000235:genetics; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D008297:Male; D009132:Muscles / Q000187:drug effects / Q000502:physiology*; D009136:Muscular Dystrophies / Q000628:therapy; D051381:Rats; D017208:Rats, Wistar; D012038:Regeneration; D001616:beta-Galactosidase / Q000235:genetics
D015500:Chloramphenicol O-Acetyltransferase; D001616:beta-Galactosidase; D002045:Bupivacaine